2026年10月16日星期五
M
مرآة العالم الشاملة
أخبار عالمية عاجلة
[Comment] Establishing cardiovascular safety of the small-molecule GLP-1 receptor agonist orforglipron in type 2 diabetes— 柳叶刀 Lancet[Comment] Making every vial count: fractional dosing of yellow fever vaccine— 柳叶刀 Lancet[Comment] Shortening treatment to accelerate hepatitis C elimination— 柳叶刀 Lancet[Comment] Offline: In praise of astrologers, sorcerers, and magicians— 柳叶刀 Lancet[World Report] “You have to be willing to take risks”: the 2026 Nobel prizes— 柳叶刀 Lancet[World Report] Health in Brazil's election— 柳叶刀 Lancet[Perspectives] Shadows and interiority— 柳叶刀 Lancet[Perspectives] Beyond the battlefield: war and global health security— 柳叶刀 Lancet[Comment] Establishing cardiovascular safety of the small-molecule GLP-1 receptor agonist orforglipron in type 2 diabetes— 柳叶刀 Lancet[Comment] Making every vial count: fractional dosing of yellow fever vaccine— 柳叶刀 Lancet[Comment] Shortening treatment to accelerate hepatitis C elimination— 柳叶刀 Lancet[Comment] Offline: In praise of astrologers, sorcerers, and magicians— 柳叶刀 Lancet[World Report] “You have to be willing to take risks”: the 2026 Nobel prizes— 柳叶刀 Lancet[World Report] Health in Brazil's election— 柳叶刀 Lancet[Perspectives] Shadows and interiority— 柳叶刀 Lancet[Perspectives] Beyond the battlefield: war and global health security— 柳叶刀 Lancet

Samsung remains top brand in Asia for third year: Nikkei Research poll

المصدر 日经 Nikkei Asiaقبل 4 ساعة
ملخص المحتوى

Samsung remains top brand in Asia for third year: Nikkei Research poll

يوفر هذا الموقع فقط فهرس العناوين والملخصات، والمحتوى الكامل وحقوق النشر مملوكة بالكامل للناشر الأصلي، يرجى النقر على رابط النص الأصلي للقراءة.

الانتقال إلى النص الأصلي
القناة التابعة
الاقتصاد والمال
المنطقة التابعة
اليابان
لغة النص الأصلي
English
رقم الإدخال
business-faee652e

Comments 0 comments

No comments yet. Be the first.

Samsung remains top brand in Asia for third year: Nikkei Research poll · مرآة العالم الشاملة